{"id":"NCT01294644","sponsor":"Kythera Biopharmaceuticals","briefTitle":"Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat","officialTitle":"Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2012-02","completion":"2012-02","firstPosted":"2011-02-11","resultsPosted":"2015-06-12","lastUpdate":"2015-06-12"},"enrollment":360,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Moderate or Severe Submental Fullness"],"interventions":[{"type":"DRUG","name":"Deoxycholic acid injection","otherNames":["ATX-101"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Deoxycholic Acid Injection 1 mg/cm²","type":"EXPERIMENTAL"},{"label":"Deoxycholic Acid Injection 2 mg/cm²","type":"EXPERIMENTAL"}],"summary":"To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).","primaryOutcome":{"measure":"Percentage of Participants With a Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) 1-grade Response","timeFrame":"Baseline and 12 weeks after last treatment (up to 24 weeks after first dose)","effectByArm":[{"arm":"Deoxycholic Acid Injection 1 mg/cm²","deltaMin":58.3,"sd":null},{"arm":"Deoxycholic Acid Injection 2 mg/cm²","deltaMin":62.3,"sd":null},{"arm":"Placebo","deltaMin":34.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":29,"countries":["Belgium","France","Germany","Italy","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":118},"commonTop":["Injection Site Pain","Injection Site Haematoma","Injection Site Swelling","Injection Site Erythema","Injection Site Anaesthesia"]}}